Andera Partners announces positive Phase 3 results for obefazimod.
The drug met primary and secondary endpoints in the maintenance phase, completing the full Phase 3 program.
See the latest news and media coverage for Andera Partners. We track all announcements, press releases, and industry mentions in real time, all in one place.
Private equity asset management firm
anderapartners.comLast updated
In short: Andera Partners surpassed €5 billion in AUM, launched a €1.1 billion mezzanine fund, and saw major portfolio successes including a $5B exit.
The drug met primary and secondary endpoints in the maintenance phase, completing the full Phase 3 program.
The merger, financed by nearly 30M€, creates a major player in the Benelux in EIM and cybersecurity.
Exciva extends Series B to €53 million with Dolby Ventures and doses first patient in Phase 2/3 SERENADA trial for Deraphan in Alzheimer's agitation. Andera funded Exciva at inception.
The transaction, financed by Allianz GI, brings the consolidated capacity to 414 MW across three geographies. Andera Partners highlights Kyotherm's growth.
Andera Partners, a leading European venture capital and private equity firm, today announced it led a $20 million Series D financing in Rivermark Medical, Inc...
Andera Partners' portfolio company Tubulis acquired by Gilead, strengthening Gilead's oncology pipeline with innovative ADC technology...
Andera Partners' franchise dedicated to sponsorless mezzanine has indeed just raised for its fifth vintage an envelope of 1.1 Bn€, exceeding its...
The international law firm Goodwin advised Andera Partners, a key player in the private equity sector dedicated to growing SMEs and mid-caps in...
Track Andera Partners and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.